Related Experiment Videos
Ceftriaxone: a third-generation cephalosporin
Abstract:
Ceftriaxone is a new third-generation cephalosporin with excellent activity against many gram-negative, and reasonable activity against most gram-positive microorganisms. Clinical studies have demonstrated its efficacy and safety in patients with bacterial meningitis; respiratory tract, urinary tract, soft tissue, bone and joint infections; and gonorrhea. Ceftriaxone has been well tolerated except for diarrhea, which in most cases has not required a change in therapy. The long elimination half-life of ceftriaxone has allowed twice- and once-daily administration, the latter potentially resulting in substantial cost savings. Because of its documented efficacy, safety, and convenient dosing schedule, ceftriaxone may become the preferred third-generation cephalosporin for the treatment of a variety of serious infections.
Insights
Ceftriaxone, a third-generation cephalosporin, shows broad-spectrum efficacy and safety for various infections. Its convenient dosing offers potential cost savings, making it a preferred treatment option.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Microbiology
Background:
- Ceftriaxone is a novel third-generation cephalosporin antibiotic.
- It exhibits significant activity against Gram-negative and moderate activity against Gram-positive bacteria.
Purpose of the Study:
- To evaluate the efficacy and safety of ceftriaxone in treating various bacterial infections.
- To assess the clinical utility of ceftriaxone based on its pharmacokinetic profile and dosing schedule.
Main Methods:
- Clinical studies were conducted to assess ceftriaxone's effectiveness.
- Safety and tolerability were monitored, including adverse events like diarrhea.
- Pharmacokinetic properties, specifically elimination half-life, were analyzed.
Main Results:
- Ceftriaxone demonstrated efficacy in treating bacterial meningitis, respiratory, urinary tract, soft tissue, bone and joint infections, and gonorrhea.
- The drug was generally well-tolerated, with diarrhea being the most common side effect, usually not requiring therapy change.
- A long elimination half-life permits twice-daily or once-daily dosing.
Conclusions:
- Ceftriaxone is an effective and safe antibiotic for numerous serious bacterial infections.
- The convenient dosing schedule, including once-daily administration, may lead to cost savings.
- Ceftriaxone is a potential preferred choice among third-generation cephalosporins for treating serious infections.